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Abstract
Background: In many epileptic women, the ovarian cycle influences the risk and severity of seizures. Previous studies have reported
inconsistent findings regarding the neural excitatory effects of estrogen. Soybean is a rich source of plant estrogens. Therefore, soy
intake can affect the risk and severity of seizures in women. Nurses and midwives need to be aware of the effects of diets containing
estrogen in pregnant and post-menopausal women, as well as during the sexual cycle periods.
Objectives: Due to the limitations of human studies, this study aimed to investigate the effect of estradiol and soy extract on the
onset of pentylenetetrazol (PTZ)-induced seizures in ovariectomized rats.
Materials and Methods: In this experimental study, sixty female Wistar rats were randomly divided into six groups of ten. All of
the groups except for the negative control groups were ovariectomized. One group received estradiol (100 µg/kg), one group was
treated with alcoholic extract of soy (20 mg/kg), and the other group received vehicle over 28 days. PTZ (90 mg/kg) was used to
induce seizure in all groups. Behavioral changes were observed over 30 minutes. All data were analyzed using a two-way analysis of
variance with Tukey’s post-hoc test.
Results: The mean± SD of the clonic seizure threshold was 61.84± 8.53 in the group that received estradiol, while it was 71.70±
10.85 in the control group, 64.69± 3.23 in rats with laparotomy without removing the ovaries, 51.30± 6.84 in rats with laparotomy
and removing the ovaries, 52.7± 7.18 in ovariectomized rats that received sesame oil as vehicle, and 59.2± 4.91, in the soy groups.
Therefore, estradiol significantly increased the clonic seizure threshold, while the alcoholic extract of soy had no effect.
Conclusions: We concluded that the chronic administration of estradiol has an anticonvulsant effect in the animal model. However,
alcoholic extract of soy has no effect on the onset of clonic seizures.
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1. Background
Sex steroids such as estrogen have regulatory effects
on neuronal excitability (1). The frequency and severity of
seizures can be altered by changes in sex hormones (2), and
they can be worse during certain phases of the menstrual
cycle (3). Catamenial epilepsy is a subset of epilepsy that
includes women whose seizures are exacerbated by their
menstrual cycle (4). The prevalence of epilepsy is 50 in
100,000 in developed countries (5). Due to the effects of
sex hormones, for many decades it was believed that there
is a direct relationship between estrogen levels and seizure
(6), and that estrogen induces excitatory actions in the cen-
tral nervous system (4). However, various studies have sug-
gested both proconvulsant (7) and anticonvulsant (8) roles
for estrogen.
Almost 50% of women who experience convulsion are
of childbearing age (9). During ovulation, reducing the ra-
tio of progesterone to estrogen might predispose women
to seizure. This ratio is reduced during the menstrual cycle,
and it is increased during the early and middle luteal cycle
(6). Changes in seizure frequency among men and women
may occur in cycles of eight to 46 days and, interestingly,
these changes sometimes occurs in cycles of 28 days, which
is similar to the female sexual cycle (10).
Women with epilepsy receive antiepileptic drugs such
as carbamazepine, oxcarbazepine, and phenobarbital.
These medications increase the risk of osteoporosis (11).
The estrogen level will decrease following ovariectomy and
menopause, which can result in hot flashes and osteoporo-
sis. Hormone replacement therapy (HRT) is usually used
to relieve such symptoms (11). Studies have shown that the
type of estrogen used in HRT is important, and that equine
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conjugated estrogen might increase the risk and severity
of seizures (12).
A traditional food source in Asia for many years, soy-
bean is a rich source of phytoestrogens (13). Phytoestro-
gens contain isoflavones, coumestans, and lignans (14).
Isoflavones display similar properties to endogenous es-
trogens and they can bond with estrogen receptors (15).
However, the estrogenic activity of phytoestrogens is poor.
Therefore, they are known as selective estrogen receptor
modulators (14). These selective estrogen receptor modu-
lators act as agonists or antagonists in different tissues (16).
Nurses and midwifes play important roles not only in con-
trolling seizures during pregnancy, but also in educating
and caring for women with convulsion. They should be
aware of the latest knowledge concerning the treatment
and prevention of convulsion in women in order to not
only educate them, but also to monitor them and reduce
the side effects of anticonvulsants. Given the side effects
of anticonvulsant drugs and HRT, as well as the effects of
phytoestrogens and soybean on estrogen receptors, a ques-
tion remains regarding whether soybean can be used as an
extrinsic source of estrogen without any associated estro-
genic side effects. If this were the case, then soy could be
used to reduce the risk and severity of seizure in women.
2. Objectives
Due to the limitations of human studies, this study
aimed to investigate the effects of the chronic admin-
istration of estradiol and alcoholic extract of soy on
pentylenetetrazol (PTZ)-induced seizure in ovariectomized
female rats.
3. Materials andMethods
3.1. Study Design and Animal Groups
In this experimental study, sixty female Wistar rats
weighing 170 - 220 gr were studied. The animals were
housed in standard cages under standard temperature
(25°C) and humidity (50% - 60%) with a 12-hour light and
dark cycle. The animals were fed with standard chow and
they had free access to water. The rats were randomly di-
vided into six groups of ten as follows: 1, CON (intact female
rats); 2, SHAM (laparotomy in the female rats without re-
moving the ovaries); 3, OVX (laparotomy in the female rats
accompanied by removal of the ovaries); 4, VEH (ovariec-
tomized rats that received sesame oil as a vehicle); 5, EST
(ovariectomized rats that received 100 µg/kg estradiol);
and 6, SOY (ovariectomized rats that received 20 mg/kg al-
coholic extract of soy).
3.2. Preparing the Materials
To prepare the hydro alcoholic extract, 100 g of pow-
dered soybean varieties (Glycine max, Barij Essence Phar-
maceutical Co.) was prepared and dissolved in 800 mL of
70% ethanol. It was then kept at room temperature for 72
hours. Then, the extract was separated through the fun-
nel. The dried extract was placed in water, alcohol, and
other additional material to evaporate for 16 hours. In or-
der to produce the drug, a certain amount of powder was
dissolved in water and a dose of 20 mg/kg was achieved.
3.3. Surgery and Treatments
The study was conducted at the physiology research
center, Kashan University of Medical Sciences. The female
rats were anaesthetized using an intraperitoneal injection
of Ketamine 100 mg/kg/ + xylazine 10 mg/kg. Then, under
aseptic conditions, the researchers laparotomized and or
ovariectomized the relevant animals. Two days after recov-
ery (17), estradiol (100 µg/kg) was injected subcutaneously
and soy extract (20 mg/kg) was gavaged daily for 28 days in
the appropriate groups.
3.4. Behavioral Study
Pentylenetetrazole (Sigma Aldrich, St. Louis, Missouri,
USA) was dissolved in sterile 0.9% saline to prepare a fresh
solution. In all study groups, the animal model of seizure
was achieved via the intraperitoneal injection of 90 mg/kg
pentylenetetrazole. The rats were placed in a Plexiglas
cage following PTZ injection and they were observed for
30 minutes. The seizure stages were classified as my-
oclonic twitch, clonic seizures, tonic hindlimb extension,
and death. Although all of these stages were observed
and their times were recorded using a chronometer, only
the clonic seizure threshold (i.e., the time until the start
of clonic seizure) was used to compare between different
groups.
3.5. Ethical Considerations
The institutional review board and the ethics commit-
tee of Kashan University of Medical Sciences approved this
study. Food and water were provided to the animals ad li-
bitum. All ethical considerations regarding the use of labo-
ratory animals were observed in light of the requirements
of the Helsinki declaration.
3.6. Statistical Analyses
We analyzed the data using SPSS statistical software,
version 13.0. All data were expressed as mean ± SD. The
Kolmogorov-Smirnov test was used to assess the normality
of the data in each group. Differences between the onset
of seizures were analyzed using two-way analysis of vari-
ance and Tukey post-hoc tests, and the difference was con-
sidered statistically significant when P < 0.05.
2 Nurs Midwifery Stud. 2016; 5(3):e33428.
Afsordeh N et al.
4. Results
As shown in Table 1, no significant difference was found
between the SHAM group and the CON group in terms of
the onset of clonic seizure. In other words, laparotomy
did not affect the onset of seizure. In addition, the onset
of clonic seizures in the VEH group was not significantly
different to that in the OVX group. In other words, use of
the sesame oil vehicle had no effect on the onset of seizure.
However, the onset of clonic seizures in the OVX group sig-
nificantly decreased compared to that in the SHAM group
(P < 0.002).
Moreover, the onset of clonic seizures increased signif-
icantly in the estradiol group compared to the VEH group
(P < 0.019) (Table 2). In addition, the results of treatment
with the soy extract did not show significant changes com-
pared to the VEH group (Table 2).
Table 1. Mean and Standard Deviation in the CON, VEH, SHAM, and OVX Rat Groups
in Terms of the Onset of Clonic Seizures Induced by PTZ in Ovariectomized Ratsa
Groups N The Onset Of Clonic Seizures (Sec)
CON 10 71.70± 10.85
SHAM 10 64.69± 3.23
OVX 10 51.30± 6.84b
VEH 10 52.7± 7.18
Abbreviations: CON (intact female rats); OVX (laparotomy in the female rats ac-
companied by the removal of the ovaries: ovariectomized rats); SHAM (laparo-
tomy in the female rats without removing the ovaries); VEH (ovariectomized
rats that received sesame oil vehicle).
aValues are expressed as mean± SD.
bP < 0.002, as compared to the SHAM group.
Table 2. Mean and Standard Deviation After 28 Days’ Administration of EST and SOY
on the Onset of Clonic Seizures Induced by PTZ in Ovariectomized Ratsa
Groups N The onset of clonic seizures (sec)
EST 10 61.84± 8.53b
SOY 10 59.2± 4.91
Abbreviations: EST (ovariectomized rats that received 100µg/kg estradiol) and
SOY (ovariectomized rats that received 20 mg/kg alcoholic extract of soy).
aValues are expressed as mean± SD.
bP < 0.019, as compared to the VEH group
5. Discussion
The present study showed that ovariectomy decreased
the onset of PTZ-induced seizure. On the other hand, estra-
diol displayed anticonvulsant effects. The protective ef-
fects of estrogen against epileptic activities have also been
reported in previous studies. Pereno et al. represented that
a Kainic acid-induced seizure model after an injection of 0.1
mg/kg of estradiol benzoate within 24 hours is neuropro-
tective in the stria terminalis (18). Moreover, the anticon-
vulsant effects of estradiol were shown in ovariectomized
rats in models of picrotoxin- (19) and cyclosporine- in-
duced seizures (20). In the current study, the prolonged
use of estradiol was found to delay the onset of seizures in
ovariectomized rats. This finding was in line with a previ-
ous study in which the prolonged usage of estrogen had
neuroprotective effects against neuronal damage-induced
seizures (21). However, another study reported that the
acute administration of estrogen significantly increases
the risk of seizures (22).
The pharmacological levels of estradiol can reversibly
decrease the N-Methyl-D-aspartic acid-induced flow, excita-
tion, and cell death of nerve cells (23). The activation of glu-
tamate or the inactivation of GABA plays an important role
in the process of creating epilepsy, (24). In another study,
subcutaneously planted estradiol capsules were used to
treat PTZ-induced seizures and it was suggested that estra-
diol may play the role of an anticonvulsant through 3α-5α-
TPH, which increases in the hippocampus and functions as
a GABAA receptor agonist (25). The effects of estrogen on
seizure depend on various factors such as duration of treat-
ment, methods of administration, or the neurotransmit-
ter in the nervous system that is involved in seizure (26).
The anticonvulsant effects of estrogen could possibly be at-
tributed to substances such as neuropeptide Y (NPY) (27),
which is a strong inhibitory neurotransmitter in the cen-
tral region of the hippocampus (28). Sex hormones might
act through different mechanisms such as changing the
gene expression, releasing neurotransmitters, and a direct
effect on neurotransmitter receptors (26).
In this study, 20 mg/kg of alcoholic extract of soy had
no effect on the onset of seizures. However, Mohammad-
pour et al. showed that the proconvulsion effect of soy
extract is dependent on the presence or absence of ovar-
ian hormones (29). Moreover, previous studies have shown
that soy extract can mimic the effects of estrogen and
so reduce the latency of myoclonic and generalized tonic
clonic seizures in ovariectomized rats (30). However, in
the present study we did not observe this effect. Nonethe-
less, earlier studies reported that phytoestrogens play ei-
ther estrogen or estrogen antagonist roles (13). Soy con-
tains the isoflavones genistein and daidzein (31). Westmark
et al. showed that the isoflavones in soybeans are effec-
tive in decreasing the threshold of seizure in mouse mod-
els and, therefore, they may increase the risk of epilepsy
(32). Westmark’s hypothesis declares that the soy phytoe-
strogens interact with the metabotropic glutamate recep-
tor and stimulate the production of the synaptic proteins
that play a key role in reducing the seizure threshold (33).
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In this study, we demonstrated that the chronic ad-
ministration of soy extract, a rich source of phytoestro-
gens, does not have a significant effect on the onset of
PTZ-induced convulsions in ovariectomized rats, while the
chronic administration of estradiol showed an anticonvul-
sant effect. The types of soy and the treatment period may
exert an influence in this regard. Yet, our results were in-
consistent with those of other studies (29, 30). Considering
the various effects of this herb, we recommend that mid-
wives and nurses assess the diet of women suffering with
seizures during different periods of the ovarian cycle, preg-
nancy, and menopause. However, it is not possible to gen-
eralize the results of this study to all humans.
Due to the controversy concerning the effects of soy ex-
tract, we recommend that its molecular effects on seizure
be further investigated. Moreover, nurses and midwives
are recommended to conduct a well-designed clinical trial
to assess the effects of soy extract on women with convul-
sion.
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